famotidine has been researched along with Cytokine Release Syndrome in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, H | 1 |
| George, SJ | 1 |
| Thompson, DA | 1 |
| Silverman, HA | 1 |
| Tsaava, T | 1 |
| Tynan, A | 1 |
| Pavlov, VA | 1 |
| Chang, EH | 1 |
| Andersson, U | 1 |
| Brines, M | 1 |
| Chavan, SS | 1 |
| Tracey, KJ | 1 |
1 other study available for famotidine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; COVID-19; Cytokine Relea | 2022 |